NCT02132936View on ClinicalTrials.gov

LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100 aerosol foam

DRUG

Aerosol foam vehicle

DRUG

Calcipotriol BDP gel

DRUG

Gel vehicle

Trial Locations (1)

31059

Service de Dermatologie, Hôspital Larrey, Toulouse

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT02132936 - LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter